Office of the Director, Office of Biotechnology Activities; Notice of Meeting, 69091 [2010-28373]

Download as PDF Federal Register / Vol. 75, No. 217 / Wednesday, November 10, 2010 / Notices Contact Person: Philippe Marmillot, PhD, Scientific Review Officer, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, 5635 Fishers Lane, Room 2019, Bethesda, MD 20892, 301–443– 2861, marmillotp@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.271, Alcohol Research Career Development Awards for Scientists and Clinicians; 93.272, Alcohol National Research Service Awards for Research Training; 93.273, Alcohol Research Programs; 93.891, Alcohol Research Center Grants; 93.701, ARRA Related Biomedical Research and Research Support Awards., National Institutes of Health, HHS) Dated: November 3, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting emcdonald on DSK2BSOYB1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 USC, as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Alcohol Abuse and Alcoholism Initial Review Group; Clinical Treatment and Health Services Research Review Subcommittee. Date: March 15–16, 2011. Time: 8:30 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Katrina Foster, PhD, Scientific Review Officer, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5635 Fishers Lane, Room 2019, Rockville, MD 20852, 301–443–4032, katrinaf@mail.nih.gov. 18:25 Nov 09, 2010 Jkt 223001 [FR Doc. 2010–28374 Filed 11–9–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Director, Office of Biotechnology Activities; Notice of Meeting BILLING CODE 4140–01–P VerDate Mar<15>2010 Dated: November 3, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. National Institutes of Health [FR Doc. 2010–28376 Filed 11–9–10; 8:45 am] (Catalogue of Federal Domestic Assistance Program Nos. 93.271, Alcohol Research Career Development Awards for Scientists and Clinicians; 93.272, Alcohol National Research Service Awards for Research Training; 93.273, Alcohol Research Programs; 93.891, Alcohol Research Center Grants; 93.701, ARRA Related Biomedical Research and Research Support Awards, National Institutes of Health, HHS) There will be a workshop entitled ‘‘Retroviral and Lentiviral Vectors for Long-Term Gene Correction: Clinical Challenges in Vector and Trial Design.’’ The meeting will be open to the public; attendance is limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: Recombinant DNA Advisory Committee. Date: December 9, 2010. Time: 8 a.m. to 5:30 p.m. Date: December 10, 2010. Time: 8 a.m. to 1 p.m. Agenda: The Office of Biotechnology Activities (OBA), NIH Recombinant DNA Advisory Committee and the European Network for the Advancement of Clinical Gene Transfer (CliniGene) will host a workshop on Retroviral and Lentiviral Vectors for Long-Term Gene Correction: Clinical Challenges in Vector and Trial Design at the Bethesda Marriott on December 9 and 10, 2010. The meeting will cover the following topics: Developments in retrovirus and lentivirus integration and insertional mutagenesis research, including nonenhancer mediated mechanisms of insertional mutagenesis; modifications to retroviral and lentiviral vectors to enhance their safety; research on in vitro and animal models to evaluate the safety of human gene transfer; and ethical issues in the design of new clinical trials. The agenda is posted to OBA’s Web site: https://oba.od.nih.gov/ rdna_rac/rac_meetings.html. Please check the meeting agenda for more information. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, Maryland 20814. Contact Person: Chezelle George, Program Assistant, Office of Science Policy, Office of Biotechnology Activities, National Institutes of Health, 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892, 301–496–9838, 301– 496–9839, georgec@mail.nih.gov. Any interested person may file written comments with the panel by forwarding the PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 69091 statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person. Background information may be obtained by contacting NIH OBA by e-mail oba@od.nih.gov Dated: November 1, 2010. Jacqueline Corrigan-Curay, Acting Director, Office of Biotechnology Activities, National Institutes of Health. [FR Doc. 2010–28373 Filed 11–9–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Interagency Autism Coordinating Committee (IACC) Subcommittee on Safety. The Interagency Autism Coordinating Committee (IACC) Subcommittee on Safety will be meeting on Monday, November 29, 2010. The subcommittee plans to discuss issues related to autism and safety. This meeting will be open to the public and will be accessible through a conference call. Name of Committee: Interagency Autism Coordinating Committee (IACC). Type of Meeting: Subcommittee on Safety. Date: November 29, 2010. Time: 9 a.m. to 12 p.m. Eastern Time. Agenda: To discuss issues related to autism and safety. Place: The Neuroscience Center, 6001 Executive Boulevard, Conference Room B1/ B2, Rockville, MD 20852. Conference Call Access: Dial: 800–369– 1754. Access code: 5105457. Cost: The meeting is free and open to the public. Registration: https:// www.acclaroresearch.com/oarc/11–29–10/. Pre-registration is recommended to expedite check-in. Seating in the meeting room is limited to room capacity and on a first come, first served basis. Access: Metro accessible—White Flint Metro (Red Line). Contact Person: Ms. Lina Perez, Office of Autism Research Coordination, National Institute of Mental Health, NIH, 6001 Executive Boulevard, NSC, Room 8185a, Rockville, MD 20852. Phone: 301–443–6040. E-mail: IACCPublicInquiries@mail.nih.gov. Please Note: The meeting will be open to the public and accessible through a conference call. Members of the public who participate using the conference call phone number will be E:\FR\FM\10NON1.SGM 10NON1

Agencies

[Federal Register Volume 75, Number 217 (Wednesday, November 10, 2010)]
[Notices]
[Page 69091]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-28373]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, Office of Biotechnology Activities; 
Notice of Meeting

    There will be a workshop entitled ``Retroviral and Lentiviral 
Vectors for Long-Term Gene Correction: Clinical Challenges in Vector 
and Trial Design.'' The meeting will be open to the public; attendance 
is limited to space available. Individuals who plan to attend and need 
special assistance, such as sign language interpretation or other 
reasonable accommodations, should notify the Contact Person listed 
below in advance of the meeting.

    Name of Committee: Recombinant DNA Advisory Committee.
    Date: December 9, 2010.
    Time: 8 a.m. to 5:30 p.m.
    Date: December 10, 2010.
    Time: 8 a.m. to 1 p.m.
    Agenda: The Office of Biotechnology Activities (OBA), NIH 
Recombinant DNA Advisory Committee and the European Network for the 
Advancement of Clinical Gene Transfer (CliniGene) will host a 
workshop on Retroviral and Lentiviral Vectors for Long-Term Gene 
Correction: Clinical Challenges in Vector and Trial Design at the 
Bethesda Marriott on December 9 and 10, 2010. The meeting will cover 
the following topics: Developments in retrovirus and lentivirus 
integration and insertional mutagenesis research, including non-
enhancer mediated mechanisms of insertional mutagenesis; 
modifications to retroviral and lentiviral vectors to enhance their 
safety; research on in vitro and animal models to evaluate the 
safety of human gene transfer; and ethical issues in the design of 
new clinical trials. The agenda is posted to OBA's Web site: https://oba.od.nih.gov/rdna_rac/rac_meetings.html. Please check the 
meeting agenda for more information.
    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, 
Maryland 20814.
    Contact Person: Chezelle George, Program Assistant, Office of 
Science Policy, Office of Biotechnology Activities, National 
Institutes of Health, 6705 Rockledge Drive, Suite 750, Bethesda, MD 
20892, 301-496-9838, 301-496-9839, georgec@mail.nih.gov.
    Any interested person may file written comments with the panel 
by forwarding the statement to the Contact Person listed on this 
notice. The statement should include the name, address, telephone 
number and, when applicable, the business or professional 
affiliation of the interested person. Background information may be 
obtained by contacting NIH OBA by e-mail oba@od.nih.gov


    Dated: November 1, 2010.
Jacqueline Corrigan-Curay,
Acting Director, Office of Biotechnology Activities, National 
Institutes of Health.
[FR Doc. 2010-28373 Filed 11-9-10; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.